Concepedia

Damon L. Meyer

DL

32

Publications

6.2K

Citations

28

H-Index

1983

Active since

Affiliations

Seagen (United States)(Current)

Fred Hutch Cancer Center

San Diego Composites (United States)

University of Washington

University Medical Center Groningen

Damon L. Meyer is an author at Seagen (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1983–2008

32

Publications

32

Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate

Kevin J. Hamblett, Peter D. Senter, Dana F. Chace et al. · Clinical Cancer Research · 2004 · 1.2K citations

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Svetlana O. Doronina, Brian E. Toki, Michael Torgov et al. · Nature Biotechnology · 2003 · 1.2K citations

, , +8

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer et al. · Blood · 2003 · 907 citations

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity

Svetlana O. Doronina, Brian A. Mendelsohn, Tim D. Bovee et al. · Bioconjugate Chemistry · 2005 · 506 citations

, , +19

Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates

Stephen C. Alley, Dennis R. Benjamin, Scott C. Jeffrey et al. · Bioconjugate Chemistry · 2008 · 456 citations

, , +18

Rows per page

1–5 of 32